Clinuvel Pharmaceuticals (ASX:CUV) has begun dosing patients in a preclinical study of its controlled-release liquid injectable peptide platform, VLRX-L. This marks the first formal test of its ...

Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...

Researchers at the UNC School of Medicine and the UNC Eshelman School of Pharmacy have made a breakthrough that could ...

- Single-dose administration of LAE102 by IV or SC injection demonstrated a favorable safety profile in the healthy participants as well as robust and prolonged target engagement in the healthy ...

LYON, France--(BUSINESS WIRE)-- Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases ...

Silo Pharma, Inc. has announced the start of a pharmacokinetic and tolerability study for its novel, non-opioid extended-release pain therapeutic, SP-26, in collaboration with AmplifyBio. The study ...

The iNSiGHT DXA system is a cutting-edge in vivo Dual Energy X-Ray Absorptiometry (DXA/DEXA) technology intended for preclinical studies. It offers a comprehensive solution for assessing a wide range ...

ROCKVILLE, Md. and SUZHOU, China, April 28, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and ...

Forbes contributors publish independent expert analyses and insights. Geri Stengel writes about the success factors of women entrepreneurs. The gender gap in healthcare isn’t just a question of equity ...